EXOME: Biotech • Healthcare • Life Sciences

National
Pfizer, BioNTech Say mRNA COVID-19 Vaccine Trials May Start This Month

Boston
Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics
Boston
Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests
Boston
Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

1.
Pfizer, BioNTech Say mRNA COVID-19 Vaccine Trials May Start This Month | National
2.
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs | Boston
3.
Investors Bet on Next-Gen Telehealth as COVID-19 Fuels Adoption | New York
4.
Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal | San Francisco
5.
Organovo Future Unclear After Shareholders Reject Tarveda Merger | San Diego
6.
Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics | Boston

Learn about the Xconomists →

Alexis Peyroles

Creating Consistent Value in Biotech Without Diluting Stakeholders

Andy Smith

Lax Approval Requirements Yield Blockbusters That Don’t Work

More Opinion, Insight, and Analysis ›

Xcelerating Life Sciences Seattle

October 1, 2020

$190M

Roche/Arrakis Therapeutics

Aravive Promotes Chief Scientific Officer Gail McIntyre to CEO

Bolt Bio Adds Mayo Clinic’s Edith Perez as Chief Medical Officer

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests
Sarah de Crescenzo | Boston
Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers
Sarah de Crescenzo | National
Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug
Frank Vinluan | Boston
Creating Consistent Value in Biotech Without Diluting Stakeholders
Alexis Peyroles | National
Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13
Editors | Boston
Millendo May Restructure After Prader-Willi Drug Fails Pivotal Test
Sarah de Crescenzo | Detroit Ann Arbor
Menlo’s Itching Drug Racks Up Two More Trial Failures, Program Ends
Frank Vinluan | New York
GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months
Frank Vinluan | San Francisco
Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment
Editors | Boston

Read More Posts ›

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
Containing Coronavirus Through Innovation and Investment
Top biotech and investment players offer their best plans and current progress in stemming and ultimately defeating the worldwide pandemic

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!